Getinge AB (GETIb.ST)

GETIb.ST on Stockholm Stock Exchange

167.60SEK
28 Jul 2014
Price Change (% chg)

-0.50kr (-0.30%)
Prev Close
168.10kr
Open
168.50kr
Day's High
172.80kr
Day's Low
167.20kr
Volume
1,267,684
Avg. Vol
1,008,862
52-wk High
244.40kr
52-wk Low
160.30kr

GETIb.ST

Chart for GETIb.ST

About

Getinge AB is a Sweden-based company active in the healthcare sector. It is engaged in the provision of products and services for intensive care units, care units, sterilization centers, elderly care and companies and institutions active in the life sciences area. Its operations are divided into three business areas. The Medical... (more)

Overall

Beta: 0.57
Market Cap (Mil.): kr37,382.64
Shares Outstanding (Mil.): 222.38
Dividend: 4.15
Yield (%): 2.47

Financials

  GETIb.ST Industry Sector
P/E (TTM): 23.36 31.20 36.09
EPS (TTM): 7.20 -- --
ROI: 4.42 9.64 18.19
ROE: 11.02 11.31 19.06
Search Stocks

NORDIC STOCKS - Factors to watch on July 24

(Adds Getinge, PGS, Rec Solar, Outokumpu, updates Danske Bank)

24 Jul 2014

BRIEF-Getinge CEO says clarity on FDA discussions may come in 1-2 months

STOCKHOLM, July 15 - Getinge CEO at conference call: * says can hopefully provide clarity on discussions with FDA in 1-2 months * For more on Getinge's Q2 report click on

15 Jul 2014

UPDATE 1-Getinge says problems in U.S. may be worse than thought

* CEO says cannot rule out FDA restrictions (Adds conference call, shares, background)

26 May 2014

BRIEF-Getinge CEO says could take months to get clarity on FDA discussions

STOCKHOLM, May 26 - Getinge AB : * CEO says sanctions that the FDA could impose on any company include fines or

26 May 2014

BRIEF-Getinge shares fall 7 pct after postpones capital markets day

STOCKHOLM, May 26 - Getinge AB : * Shares fall 7 percent after postpones capital markets day due to FDA

26 May 2014

UPDATE 1-Getinge profit dips less than expected under shadow of quality issues

* Shares marginally higher, in line with broader market (Adds detail, background)

16 Apr 2014

RPT-Getinge Q1 profit falls less than expected

STOCKHOLM, April 16 - Swedish medical technology firm Getinge posted a 15.4 percent fall in first-quarter core profit on Wednesday, better than analyst had forecast, and saw restructuring costs for the year swelling to 960 million crowns.

16 Apr 2014

Getinge Q1 profit falls less than expected

STOCKHOLM, April 16 - Swedish medical technology firm Getinge posted a 15.4 percent fall in first-quarter core profit on Wednesday, better than analyst had forecast, and saw restructuring costs for the year swelling to 960 million crowns.

16 Apr 2014

BRIEF-Getinge stands by guidance for 2014 growth on par with 2013

STOCKHOLM, April 16 - Getinge AB : * Says the organic volume growth for the current year is expected to be

16 Apr 2014

Swedish firm Getinge suspends employee in insider trading probe

STOCKHOLM, April 11 - Swedish medical technology group Getinge said on Friday that one of its employees was under investigation by the Swedish authorities for suspected insider trading.

11 Apr 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Thomson Reuters StreetEvents
$75.00
Provider: GlobalData
$250.00
Provider: Thomson Reuters StreetEvents
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks